489 related articles for article (PubMed ID: 18645275)
1. Expression of vascular endothelial growth factor, receptor KDR and p53 protein in transitional cell carcinoma of the bladder.
Liu L; Zhu D; Gao R; Guo H
Urol Int; 2008; 81(1):72-6. PubMed ID: 18645275
[TBL] [Abstract][Full Text] [Related]
2. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
Suzuki K; Morita T; Tokue A
Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
[TBL] [Abstract][Full Text] [Related]
4. [The correlation of vascular endothelial growth factor with angiogenesis and p53 gene in laryngeal squamous cell carcinoma].
Yaylaci A; Cakir S; Güneş P; Akkaynak AC; Naiboğlu B; Gökçeer T
Kulak Burun Bogaz Ihtis Derg; 2006; 16(3):105-11. PubMed ID: 16763427
[TBL] [Abstract][Full Text] [Related]
5. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR].
Chen XL; Liu LC; Xu ZG; Li Z; Li RW; Gao RJ; Wang S; Zhang M; Guo H
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):578-82. PubMed ID: 19102933
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of vascular endothelial growth factor165b in transitional cell carcinoma of the bladder.
Das K; Zhao Y; Sugiono M; Lau W; Tan PH; Cheng C
Urol Oncol; 2007; 25(4):317-21. PubMed ID: 17628298
[TBL] [Abstract][Full Text] [Related]
7. [Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in superficial transitional cell bladder carcinoma].
Guo ZH; Mei H; Huang J; Li SY
Ai Zheng; 2003 Mar; 22(3):307-9. PubMed ID: 12654193
[TBL] [Abstract][Full Text] [Related]
8. The expression of vascular endothelial growth factor in transitional cell carcinoma of urinary bladder is correlated with cancer progression.
Yang CC; Chu KC; Yeh WM
Urol Oncol; 2004; 22(1):1-6. PubMed ID: 14969795
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y
Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074
[TBL] [Abstract][Full Text] [Related]
10. Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer.
Xia G; Kumar SR; Hawes D; Cai J; Hassanieh L; Groshen S; Zhu S; Masood R; Quinn DI; Broek D; Stein JP; Gill PS
J Urol; 2006 Apr; 175(4):1245-52. PubMed ID: 16515971
[TBL] [Abstract][Full Text] [Related]
11. Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma.
Kondo Y; Arii S; Furutani M; Isigami S; Mori A; Onodera H; Chiba T; Imamura M
Cancer; 2000 Apr; 88(8):1820-7. PubMed ID: 10760758
[TBL] [Abstract][Full Text] [Related]
12. [Expression of p53 and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinical significance].
Liu DB; Chen KN; Cao XZ; Wang T
Ai Zheng; 2002 Sep; 21(9):989-93. PubMed ID: 12508548
[TBL] [Abstract][Full Text] [Related]
13. [The effects of the expression of VEGF and KDR on the angiogenesis, growth and metastasis of hepatocellular carcinoma].
Zhao A; Dou K; Li K; Fu Y
Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):453-6. PubMed ID: 11832083
[TBL] [Abstract][Full Text] [Related]
14. [Expression of VEGF and tumor angiogenesis in bladder cancer].
Wang S; Xia T; Zhang Z; Kong X; Zeng L; Mi P; Xue Z
Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):34-6. PubMed ID: 11831983
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer.
Crew JP; O'Brien T; Bradburn M; Fuggle S; Bicknell R; Cranston D; Harris AL
Cancer Res; 1997 Dec; 57(23):5281-5. PubMed ID: 9393750
[TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma].
Sha D; He YJ
Ai Zheng; 2006 Feb; 25(2):229-34. PubMed ID: 16480593
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer.
Patel NS; Dobbie MS; Rochester M; Steers G; Poulsom R; Le Monnier K; Cranston DW; Li JL; Harris AL
Clin Cancer Res; 2006 Aug; 12(16):4836-44. PubMed ID: 16914569
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of angiogenesis, p-53 tissue protein expression and serum VEGF in patients with endometrial cancer.
Mazurek A; Pierzyński P; Kuć P; Kopinski P; Terlikowski S; Niklińska W; Trojan J; Laudański T
Neoplasma; 2004; 51(3):193-7. PubMed ID: 15254672
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor-C expression in bladder transitional cell cancer and its relationship to lymph node metastasis.
Zu X; Tang Z; Li Y; Gao N; Ding J; Qi L
BJU Int; 2006 Nov; 98(5):1090-3. PubMed ID: 17034609
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor and receptor flk-1 in colon cancer liver metastases.
Cheng J; Slavin RE; Gallagher JA; Zhu G; Biehl TR; Swanstrom LL; Hansen PD
J Hepatobiliary Pancreat Surg; 2004; 11(3):164-70. PubMed ID: 15235888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
